You Ni

State Key Laboratory Of Medical Neurobiology
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

An exploratory 18F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease.

An exploratory 18F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 21, 2026

Clinical features, outcome and HLA subtypes in Eastern patients with anti-IgLON5 disease: a multicenter study.

Clinical features, outcome and HLA subtypes in Eastern patients with anti-IgLON5 disease: a multicenter study.

Journal: Orphanet journal of rare diseases

Published: November 25, 2025

Impact of deep brain stimulation on cognitive impairment in Parkinson's disease: A retrospective longitudinal study.

Impact of deep brain stimulation on cognitive impairment in Parkinson's disease: A retrospective longitudinal study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 23, 2024

Assessing Plasma APLP1 for the Progression of Parkinson's Disease: Insights from HSPD and PPMI Cohorts.

Assessing Plasma APLP1 for the Progression of Parkinson's Disease: Insights from HSPD and PPMI Cohorts.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 28, 2024

Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.

Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.

Journal: Brain : a journal of neurology

Published: June 28, 2024

A Tau PET tracer PBB3 binds to TMEM106B amyloid fibril in brain.

A Tau PET tracer PBB3 binds to TMEM106B amyloid fibril in brain.

Journal: Cell discovery

Published: September 07, 2023

Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice.

Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice.

Journal: Biomedicines

Published: July 16, 2023

Anti-IgLON5 disease: a novel topic beyond neuroimmunology.

Anti-IgLON5 disease: a novel topic beyond neuroimmunology.

Journal: Neural regeneration research

Published: October 18, 2022

Hybrid 18F-florbetapir PET/MRI for assessing myelin recovery in GFAP-A patients.

Hybrid 18F-florbetapir PET/MRI for assessing myelin recovery in GFAP-A patients.

Journal: Translational neuroscience

Published: March 20, 2022

The clinical and neuroimaging features of sporadic adult-onset neuronal intranuclear inclusion disease.

The clinical and neuroimaging features of sporadic adult-onset neuronal intranuclear inclusion disease.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: February 07, 2022

Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice.

Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice.

Journal: Journal of neuroinflammation

Published: November 12, 2021

FoxP3- Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines.

FoxP3- Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines.

Journal: Frontiers in neurology

Published: August 08, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026